Dengue virus neither directly mediates hyperpermeabi lity nor enhances tumor necrosis factor-α-induced permeability in vitro

Japanese Journal of Infectious Diseases

Volumn 67, Issue 2, 2014, Pages 86-94

  Raekiansyah, Muhareva ^a   Espada Murao, Lyre Anni ^a   Okamoto, Kenta ^a   Kubo, Toru ^a   Morita, Kouichi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DENGUE VIRUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; CAPILLARY PERMEABILITY; CELLS, CULTURED; DENGUE; DENGUE VIRUS; ENDOTHELIAL CELLS; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897846648     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.67.86     Document Type: Article

References (56)

1. Halstead, S.B. (2007): Dengue. Lancet, 370, 1644-1652.
2. Henchal, E.A. and Putnak, J.R. (1990): The dengue viruses. Clin. Microbiol. Rev., 3, 376-396.
3. Special Programme for Research and Training in Tropical Diseases/ World Health Organization (TDR/WHO) (2009): Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Diagnostics Evaluation Series No. 3. TDR/WHO, Geneva, Switzerland.
4. Rothman, A.L. and Ennis F.A. (1999): Immunopathogenesis of dengue hemorrhagic fever. Virology, 257, 1-6.
5. Hunt, N.H., Golenser, J., Chan-Ling, T., et al. (2006): Immunopathogenesis of cerebral malaria. Int. J. Parasitol., 36, 569-582.
6. Steinberg, B.E., Goldenberg, N.M. and Lee W.L. (2012): Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods. Antiviral Res., 93, 2-15.
7. Andrews, B.S., Theofilopoulos, A.N., Peters C.J., et al. (1978): Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect. Immun., 20, 776-781.
8. Dalrymple, N. and Mackow, E.R. (2011): Productive dengue virus infection of human endothelial cells is directed by heparan sulfate- containing proteoglycan receptors. J. Virol., 85, 9478-9485.
9. Peyrefitte, C.N., Pastorino, B., Grau, G.E., et al. (2006): Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes. J. Med. Virol., 78, 229-242.
10. Jessie, K., Fong, M.Y., Devi, S., et al. (2004): Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in site hybridization. J. Infect. Dis., 189, 1411-1418.
11. Zellweger, R.M., Prestwood, T.R. and Shresta, S. (2010): Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe, 7, 128-139.
12. Avirutnan, P., Malasit, P., Seliger, B., et al. (1998): Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol., 161, 6338-6346.
13. Limonta, D., Capoá, V., Torres, G., et al. (2007): Apoptosis in tissues from fatal dengue shock syndrome. J. Clin. Virol., 401, 50-54.
14. Dewi, B.E., Takasaki, T. and Kurane, I. (2004): In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J. Virol.Methods, 121, 171-180.
15. Talavera, D., Castillo, A.M., Dominguez, M.C., et al. (2004): IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J. Gen. Virol., 85, 1801-1813.
16. Rothman, A.L. (2011): Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol., 11, 532-543.
17. Schmid, E.F., Binder, K., Grell, M., et al. (1995): Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor a. Blood, 86, 1836-1841.
18. Kinney, R.M., Butrapet, S., Chang, G.J., et al. (1997): Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology, 230, 300-308.
19. Okamoto, K., Kinoshita, H., Parquet Mdel, C., et al. (2012): Dengue virus strain DEN2 16681 utilizes a specific glycochain of syndecan-2 proteoglycan as a receptor. J. Gen. Virol., 93, 761-770.
20. Gavrilovskaya, I.N., Gorbunova, E.E., Mackow, N.A., et al. (2008): Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirusdirected permeability. J. Virol., 82, 5797-5806.
21. Pfaffl, M.W. (2001): A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, 2003-2007.
22. δ δCT method. Methods, 25, 402-408.
23. Chagan-Yasutan, H., Ndhlovu, L.C., Lacuesta, T.L., et al. (2013): Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection. J. Clin. Virol., 58, 635-640.
24. Gillies, M.C. and Su, T. (1995): Interferon-a2b enhances barrier function of bovine retinal microvascular endothelium in vitro. Microvasc. Res., 49, 277-288.
25. Kraus, J., Ling, A.K., Hamm, S., et al. (2004): Interferon-b stabilizes barrier characteristics of brain endothelial cells in vitro. Ann. Neurol., 56, 192-205.
26. Warke, R.V., Xhaja, K., Martin, K.J., et al. (2003): Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J. Virol., 77, 11822-11832.
27. Hober, D., Delannoy, A.S., Benyoucef, S., et al. (1996): High levels of sTNFR p75 and TNFa in dengue-infected patients. Microbiol. Immunol., 40, 569-573.
28. Bosch, I., Xhaja, K., Estevez, L., et al. (2002): Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J. Virol., 76, 5588-5597.
29. Liew, K.J. and Chow, V.T. (2006): Microarray and real-time RTPCR analyses of a novel set of differentially expressed human genes in ECV304 endothelial-like cells infected with dengue virus type 2. J. Virol. Methods, 131, 47-57.
30. Drexler, H.G., Quentmeier, H., Dirks, W.G., et al. (2002): Bladder carcinoma cell line ECV304 is not a model system for endothelial cell. In Vitro Cell. Dev. Biol. Anim., 38, 185-186.
31. Azizan, A., Sweat, J., Espino, C., et al. (2006): Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus. J. Virol. Methods, 138, 211-217.
32. Azizan, A., Fitzpatrick, K., Signorovitz, A., et al. (2009): Profile of time-dependent VEGF upregulation in human pulmonary endothelial cells, HPMEC-ST1.6R infected with DENV-1, -2, -3, and -4 viruses. Virol. J., 6, 49.
33. Nooteboom, A.T., Hendriks, I., Ottehoäller, et al. (2000): Permeability characteristics of human endothelial monolayers seeded on different extracellular matrix proteins. Mediators. Inflamm., 9, 235-241.
34. Weiss, T.L., Selleck, S.E., Reusch, M., et al. (1990): Serial subculture and relative transport of human endothelial cells in serumfree, defined conditions. In Vitro Cell. Dev. Biol., 26, 759-768.
35. Areá valo, M.T., Simpson-Haidaris, P.J., Kou, Z., et al. (2009): Primary human endothelial cells support direct but not antibodydependent enhancement of dengue viral infection. J. Med. Virol., 8, 519-528.
36. Diamond, M.S., Edgil, D., Roberts, T.G., et al. (2000): Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol., 74, 7814-7823.
37. Klimstra, W.B., Ryman, K.D. and Johnston, R.E. (1998): Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol., 72, 7357-7366.
38. Minagar, A., Long, A., Ma, T.H., et al. (2003): Interferon (IFN)- b1a and IFN-b1b block IFN-g-induced disintegration of endothelial junction integrity and barrier. Endothelium, 10, 299-307.
39. Kiss, J., Yegutkin, G.G., Koskinen, K., et al. (2007): IFN-b protects from vascular leakage via up-regulation of CD73. Eur. J. Immunol., 37, 3334-3338.
40. Morrell, C.N., Srivastava, K., Swaim, A., et al. (2011): Beta interferon suppresses the development of experimental cerebral malaria. Infect. Immun., 79, 1750-1758.
41. da Silva, A.J., Brickelmaier, M., Majeau, G.R., et al. (2002): Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-a2b vs. IFN-b1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res., 22, 173-188.
42. Narravula, S., Lennon, P.F., Mueller, B.U., et al. (2000): Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J. Immunol., 165, 5262-5268.
43. Gomez, D. and Reich, N.C. (2003): Stimulation of primary human endothelial cell proliferation by IFN. J. Immunol., 170, 5373-5381.
44. Ferrara, N. (1999): Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int., 56, 794-814.
45. Kuruganti, P.A., Hinojoza, J.R., Eaton, M.J., et al. (2002): Interferon- b counteracts inflammatory mediator-induced effects on brain endothelial cell tight junction molecules-implications for multiple sclerosis. J. Neuropathol. Exp. Neurol., 61, 710-724.
46. Liu, P.,Woda, M., Ennis, F. A., et al. (2009): Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. J. Infect. Dis., 200, 191-201.
47. da Conceiçaã o, T.M., Rust, N.M., Berbel, A.C., et al. (2012): Essential role of RIG-I in the activation of endothelial cells by dengue virus. Virology, 435, 281-292.
48. McIntyre, T.M., Modur, V., Prescott, S.M., et al. (1997): Molecular mechanisms of early inflammation. Thromb. Haemost., 78, 302-305.
49. Dewi, B.E., Takasaki, T. and Kurane, I. (2008): Peripheral blood mononuclear cells increase the permeability of dengue virusinfected endothelial cells in association with downregulation of vascular endothelial cadherin. J. Gen. Virol., 89, 642-652.
50. Huang, Y.H., Lei, H.Y., Liu, H.S., et al. (2000): Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am. J. Trop. Med. Hyg., 6, 71-75.
51. Pang, T., Cardosa, M.J. and Guzman, M.G. (2007): Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic feverdengue shock sydnrome (DHF/DSS). Immunol. Cell Biol., 85, 43-45.
52. Juffrie, M., van Der Meer, G.M., Hack, C.E., et al. (2000): Inflammatory mediators in dengue virus infection in children: interleukin- 8 and its relationship to neutrophil degranulation. Infect. Immun., 68, 702-707.
53. Luscinskas, F.W., Gerszten, R.E., Garcia-Zepeda, E.A., et al. (2000): C-C and C-X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Ann. N. Y. Acad. Sci., 902, 288-293.
54. Dalrymple, N.A. and Mackow, E.R. (2012): Endothelial cells elicit immune-enhancing responses to dengue virus infection. J. Virol., 86, 6408-6415.
55. Souza, D.G., Fagundes, C.T., Sousa, L.P., et al. (2009): Essential role of platelet-activating factor receptor in the pathogenesis of dengue virus infection. Proc. Natl. Acad. Sci. USA, 106, 14138-14143.
56. Ishii, S. and Shimizu, T. (2000): Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res., 39, 41-82.